Name: OncoStem Financials 2026 – Revenue, P&L & Cash Flow
Creator: Inc42 Datalabs

OncoStem

Private

Oncostem Diagnostics Private Limited

Private

Oncostem Diagnostics Private Limited

2011

Founded in 2011, OncoStem operates in Health Tech industry. Initially focused on offering diagnostic tests for breast cancer, the company has expanded its scope to address other cancers using its prop...

Funding stage:

Series A

Last funding:

05/09/2017

Total funding:

$6.00 Mn+

Revenue:

₹10.0 Cr+ (FY25)

Prev. FY

Investors

Employee count:

Last 90d

Web traffic:

806

Last 30d

Glassdoor Rating:

OncoStem: Financial Breakdown

Decoding financial health metrics of OncoStem

Total Revenue
₹7.8 Cr
2%
Prev. FY
Total Expenses
₹9.3 Cr
10%
Prev. FY
Profit After Tax
₹-1.6 Cr
-77%
Prev. FY
Total Assets
₹12.0 Cr
344%
Prev. FY
Net Profit Margin
-20.3%
-72%
Prev. FY

Note: Above mentioned stats are for FY20-21

FAQs on Financials of OncoStem

Yes. In FY25, OncoStem reported a profit after tax of ₹3.7 Cr, making it profitable.

OncoStem's revenue grew 40.0% year-on-year, from ₹7.2 Cr in FY24 to ₹10.0 Cr in FY25.

In FY25, OncoStem posted revenue of ₹10.0 Cr (up 40.0% YoY) and a profit after tax of ₹3.7 Cr. Explore the full financials of OncoStem here...

Disclaimer

Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.

Quick Links

OncoStem - Financials, Revenue, P&L Statement, Balance Sheet, Cash Flow & More

OncoStem: Financial Breakdown

FAQs on Financials of OncoStem

Is OncoStem profitable?

What is OncoStem's growth rate?

How is OncoStem's business performing?

Disclaimer